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Non-typhoid Salmonella strains containing virulence plasmids are highly associated with bacter-
emia and disseminated infection in humans. These plasmids are found in Salmonella serovars
adapted to domestic animals, such as Salmonella dublin and Salmonella choleraesuis, as well as in
the widely distributed pathogens Salmonella typhimurium and Salmonella enteritidis. Although
virulence plasmids differ between serovars, all contain a highly conserved 8-kb region containing
the spv locus that encodes the spvR regulatory gene and four structural spvABCD genes. Studies in
mice suggest that the spvgenes enhance the ability of Salmonella strains to grow within cells of the
reticuloendothelial system. The spv genes are not expressed during exponential growth in vitro
but are rapidly induced following entry of Salmonella strains into mammalian cells, including
macrophages. Transcription of the spv genes is controlled by the stationary-phase (T factor RpoS,
and mutations in RpoS abolish virulence. These studies suggest that the ability of Salmonella strains
to respond to starvation stress in the host tissues is an essential component of virulence.
Organisms ofthe genus Salmonella cause three distinct clini-
cal syndromes: (1) gastroenteritis, (2) enteric (typhoid) fever,
and (3) septicemia, with frequent metastatic foci of infection.
The most common manifestation of salmonella infection is
self-limited enteritis, and dissemination of bacteria outside of
the gastrointestinal tract is unusual in the healthy host. In con-
trast, systemic disease is the hallmark of enteric fever, with
bacteremia and infection of lymphoid tissue and the reticuloen-
dothelial system. Clinical gastroenteritis is not prominent, but
late complications of Peyer's patch infection, which involve
perforation and hemorrhage, are particularly distinctive fea-
tures of enteric fever and are uncommon in other salmonella
infections. Disseminated disease is also seen in the third form
ofsalmonellosis, but in this syndrome, severe sepsis may domi-
nate the clinical picture or patients may present with localized
foci of infection; gastrointestinal symptoms may be mild or
absent, and the bowel complications seen in enteric fever are
not present [1].
Although a very large number of distinct Salmonella strains
have been identified by a combination of serological, biologi-
cal, and genetic techniques, a limited number of strains have
been shown to be closely associated with either the enteric
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fever or septicemia syndromes. Only Salmonella typhi and,
occasionally, Salmonella paratyphi serovars have been shown
to cause typhoid fever. These strains are host adapted to humans
and do not cause disease in animals. Both Salmonellacholerae-
suis and Salmonella dublin are strongly associated with the
septicemic/metastatic form of salmonellosis, while these organ-
isms are uncommon causes of gastroenteritis in humans [1,
2]. In contrast, >2,000 different serovars have been identified
among isolates from patients with gastroenteritis, and a few of
these, notably Salmonella typhimurium and Salmonellaenterit-
idis, are also prominent isolates in cases of salmonella bacter-
emia [2].
These observations indicate that Salmonella strains differ
in their ability to produce particular disease syndromes. The
molecular genetic basis for the different virulence traits among
these strains remains poorly understood. However, recent evi-
dence indicates that a common plasmid-encoded genetic locus
is a major determinant of virulence in non-typhoid Salmonella
serovars associated with systemic disease [3,4]. Virulence plas-
mids in Salmonella strains were identified by several early
studies in which large "cryptic" plasmids were cured, and the
plasmid-free derivatives were found to be less virulent in mice.
Subsequent studies in which virulence was restored by reintro-
duction of the plasmids provided definitive evidence for plas-
mid-encoded virulence genes [3, 4].
Distribution of Virulence Plasmids in Salmonella
Serovars
Virulence plasmids are found in only a small number of
Salmonella serovars, and these can be divided into two groups
based on their epidemiology. One group consists of serovars
that are host adapted to domestic animals: S. dublin (cattle),
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S. choleraesuis(pigs), Salmonellagallinarum-pullorum (fowl),
and Salmonellaabortusovis (sheep) [5, 6]. The host adaptation
is reflected by the observations that the particular serovar is
frequently associated with disseminated disease in its host spe-
cies but is usually not found in other animal species. S. dublin
and S. choleraesuis are also associated with systemic disease
in humans, while S. gallinarum-pullorum and S. abortusovis
are not human pathogens. It is significant that virulence plas-
mids have not been found in S. typhi, despite its properties of
human adaptation and propensity to cause systemic illness [5].
The second group ofSalmonellastrains carrying virulence plas-
mids are the broad host-range serovars S. typhimurium and S.
enteritidis [5]. These organisms are isolated from a variety of
hosts and are prominent causes of both the gastroenteritis and
septicemia syndromes in humans.
Virulence plasmids range in size from 50 kb to 100 kb, and
considerable differences exist between plasmids from individ-
ual serovars. However, plasmids isolated from strains ofa given
serovar are remarkably similar. These observations suggest that
the plasmids are specific to the particular serovar and that
little if any plasmid exchange occurs between serovars. These
findings are consistent with the apparent absence of complete
self-transmissible conjugation systems on the virulence plas-
mids [7]. Heteroduplex analysis indicates that the larger S.
typhimurium plasmid (l00 kb) contains a region hybridizing
to virtually all of the S. enteritidis plasmid (60 kb) and almost
all of the S. choleraesuis plasmid (50 kb). In contrast, large
regions of the S. dublin plasmid (80 kb) appear unrelated to
any of the sequences of the other virulence plasmids tested [8].
Despite these differences, the plasmid from S. enteritidis was
found to restore mouse virulence to a plasmid-cured S. dublin
strain [9]. In a similar vein, the plasmid from S. gallinarum-
pullorum is able to substitute for the S. typhimurium plasmid
in mouse virulence, despite the fact that S. gallinarum-pullorum
strains are not virulent in mice [10]. The results indicate that
virulence plasmids are not responsible for the host-adaptation
phenotype, but rather encode a common virulence function that
is interchangeable among the host serovars. Subsequent studies
have identified a highly conserved region of ~8 kb, designated
spv for Salmonella plasmid virulence, present on all the plas-
mids and responsible for the virulence phenotype in mice. The
spv locus consists of the spvR regulatory gene and four struc-
tural genes, spvABCD.
Contribution of the spv Locus to the Virulence of
Salmonella Serovars
Most of the work on the virulence plasmid phenotype has
been done with inbred mice homozygous for the Itys locus.
These mice are much more susceptible to Salmonella strains
than are animals carrying the Ity" allele. In Itys mice, S. typhi-
murium, S. dublin. S. enteritidis. and S. choleraesius strains
cured of their respective plasmids are }O1. to }06-fold less
virulent than their isogenic wild-type parent strains [3, 4]. This
loss of virulence is generally seen whether the inoculum is
given intraperitoneally or orally, although certain S. typhimu-
rium strains may show a plasmid effect only with oral infection
[11]. The plasmid virulence phenotype is also expressed in Ity"
mice. Detailed studies on the pathogenesis and histopathology
of oral salmonella infection in mice show that the plasmid is
not required for invasion ofthe bacteria into intestinal epithelial
cells and Peyer's patches, nor for spread to mesenteric nodes
and the reticuloendothelial system (RES) of the liver and
spleen. Instead, the plasmid-containing strains outgrow plas-
mid-free bacteria in the RES, leading to an overwhelming in-
fection characterized by prominent microabscess formation and
large numbers of organisms in the liver and spleen prior to
death at 6-8 days after inoculation [12]. The plasmid-free
strain of S. dublin was found to invade the bowel wall and
ileal Peyer's patches with an efficiency equal to that of the
wild-type parent strain. However, plasmid-free bacteria in the
mesenteric lymph nodes and the spleen increased much more
slowly than wild-type, remaining 102_ to 103-fold lower in
number at 7 days after infection. After 10 days, the number of
plasmid-free bacteria decreased and the liver histology showed
numerous small granulomas. These results indicate that the
slower growth of plasmid-free strains allows the host to mount
an effective immune response. Polymorphonuclear leukocytes
do not appear to be important in controlling the initial growth
ofplasmid-free strains, since the numbers ofbacteria recovered
from neutropenic mice over the first 7 days of infection were
the same as those for control mice [12].
Several lines of evidence suggest that the virulence plasmid
enhances bacterial growth within the intracellular environment
of host cells. In the murine model, Salmonella strains rapidly
enter cells following inoculation [13]. Gentamicin treatment of
mice infected with plasmid-containing S. dublin does not alter
the lethal course of infection, owing to the inability of the
antibiotic to enter host cells. However, mice are cured ofsalmo-
nella infection by the administration ofgentamicin incorporated
into liposomes, which enables delivery of the drug to the intra-
cellular environment [14]. Results ofstudies in which a temper-
ature-sensitive marker plasmid is used in S. typhimurium sug-
gest that the virulence plasmid accelerates intracellular growth
of bacteria in the liver and spleen [15], and recent evidence
indicates that the vast majority of viable plasmid-containing
bacteria in the spleen are found in the macrophages within 3
days after infection (N. A. Buchmeier, unpublished observa-
tions). Plasmid-containing strains do not appear to cause any
general immunosuppression, since the growth of plasmid-free
strains is not enhanced by mixed infection [16]. Results of
these in vivo studies suggest that the virulence plasmid in-
creases bacterial growth within macrophages of the RES, al-
though growth within other host cells may occur as well.
Only limited studies of the virulence plasmid phenotype have
been done in humans and domestic animal hosts. The virulence
plasmid is required for S. gal/inarum-pullorum to produce se-
vere systemic disease in fowl [17]. The S. choleraesuisplasmid
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Figure 1. Map of known genetic loci on the Salmonella dublin
virulence plasmidpSDL2. A regionencoding autonomous replication
functions is located clockwise fromthe single Xba I site.Theessential
virulence locus consists of the five spvRABCD genes, bordered by a
1S630-like element upstream and orjE downstream. A regionaffect-
ing plasmid stability constitutes a multimer resolution system, com-
posed of a gene for resolvase (rst!) and a crossover site for specific
recombination (crs), leading to the conversion of plasmid multimers
to monomers.
--...- ......
--...-
a region of indirect repeats homologous to oriVl of F. The
rsdlcrs system is capable of resolving multimers generated
in recA+ hosts and of stabilizing heterologous replicons in
Salmonella strains. A resolvase function active on crs was
found in other Salmonella serovars harboring a virulence plas-
mid, suggesting that this system is a general mechanism for
virulence plasmid stabilization.
Deletion and insertion mutagenesis has been used to define
the plasmid genes essential for virulence in S. dublin. Tn5-oriT
insertions in orjE retain virulence, but deletion ofspvD partially
attenuates virulence [20]. Tn5-oriT inserts in spvR, spvB, and
spvC abolish virulence [20]. Due to the polar nature of InS
inserts, non-polar mutations using an Xba I linker oligonucleo-
tide were also constructed [23]. Analysis of these plasmids
showed that spvA is not essential for virulence in mice. Muta-
tions throughout spvB are nonvirulent, including stop-codon
inserts close to the COOH-terminus. Mutations in spvC and
spvD are partially virulent but the plasmids are unstable in
vivo. Insertions in spvR are avirulent and abolish production
of the SpvABCD proteins, consistent with the essential regula-
tory role of spvR (see below). Taken together, the results indi-
cate that spvR and spvB are essential virulence genes in mice
and that spvC and spvD have accessory roles and are probably
needed for full virulence, while spvA is not essential. In
:¥J;~'-l AR~B Je.¥' \;..QCiJe. \
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\
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Molecular Analysis of the S. dublin Plasmid pSDL2
In early studies in which insertion mutations and deletions
were used, a single virulence region on the S. dublin plasmid
was identified, as well as a fragment capable of autonomous
replication (figure I) [9]. Subsequent experiments showed that
an 8.2-kb segment from the virulence region cloned on an IncP
plasmid replicon could restore virulence to a plasmid-cured
S. dublin strain. Complete sequence analysis of this fragment
revealed six open reading frames, currently designated
spvRABCD and orjE (figure I) [20]. Comparison with spv se-
quences from S. typhimurium and S. choleraesuis show <0.5%
divergence at the nucleotide level [3]. An insertion sequence-
like element related to 18630 is located upstream from spvR
[21]. Early work identified a region downstream from orjE
required for plasmid stability [9]. This region was found to
contain a resolvase (rsd) closely related to the D protein of
miniF and a cis-acting resolution site, designated crs [22]. The
crs element contains eight direct, incomplete 17-bp repeats and
also appears to enhance disease in pigs [18]. Since only a
portion of S. typhimurium strains carry a virulence plasmid, it
is possible to use molecular epidemiology to determine whether
plasmid-containing strains are more closely associated with
systemic disease than with gastroenteritis. By using this ap-
proach, we have found that 76% of strains isolated from blood
cultures but only 42% of unrelated fecal isolates carried a
virulence plasmid; these findings provide evidence that the
virulence plasmid plays a significant role in human disease
[19]. Similar results have also been reported in studies of do-
mestic livestock [8]. These findings confirm the general sig-
nificance of virulence plasmids in systemic disease due to non-
typhoid Salmonella serovars.
The absence of virulence plasmid sequences in S. typhi and
the S. paratyphi serovars associated with enteric fever suggests
that the pathogenesis of typhoid is quite different from that of
disseminated, non-typhoid salmonellosis. Another difference is
the presence of the Vi capsule in S. typhi and its absence
in most virulence plasmid-containing isolates. S. typhi is not
pathogenic for mice, and introduction of a virulence plasmid
does not restore virulence in murine infections [5]. This result
indicates that crucial differences in chromosomal genes exist
between S. typhi and the mouse virulent serovars. Chromo-
somal loci required for mouse virulence are also missing from
a number of non-typhoid serovars. Transfer of a virulence plas-
mid to the Salmonella serovars S. derby, S. havana, S. minne-
sota, S. ohio, and S. saintpaul failed to confer mouse virulence
on these strains, while S. heidelberg and S. newport were ren-
dered virulent [5]. These studies indicate that both the virulence
plasmid and the chromosome are key determinants of mouse
virulence. Since S. typhi differs in both of these elements,
salmonellosis in mice has severe limitations as a model for
typhoid fever and more likely parallels the septicemia syn-
drome.
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S. typhimurium, spvC and spvD have significant roles in mouse
virulence [24, 25].
The spv genes are transcribed from two promoter regions,
one located upstream from spvR and the second positioned
between spvR and spvA [26]. Transcription of the spvABCD
genes is initiated upstream from spvA, and messages for spvA,
spvAB, spvABC, and spvABCD are found in decreasing abun-
dance. LacZ translational fusions to the Spv proteins are also
expressed with the same decreasing activity, SpvA being high-
est and SpvD lowest [26]. These findings suggest that tran-
scripts initiate at the spvA promoter and can terminate within
each ofthe long intergenic regions. However, a complex system
of termination and mRNA processing cannot be excluded. The
promoter for spvR has not been localized, but a monocistronic
message is found, indicating that spvR transcription normally
terminates before the spvA gene (M. Krause and D. G. Guiney,
unpublished observations).
log phase cells
R ABC 0 plasmid
- - - --e::>-c:>=:>-c - - - spv
genes
rpoS
~
stationary!intracellular
phase environment
in vitro in vivo
)0 spv transcripts
)0
Regulation of spv Expression
The discovery that spv expression varies during the bacterial
growth phase provided the key to understanding the mechanism
of spv gene regulation shown in figure 2 [27]. When LacZ
translational fusions were used, the expression of spvABCD
was found to be very low in early log-phase cells and to in-
crease rapidly in the post-exponential phase [26, 27]. This
growth-phase regulation was confirmed by analysis of spv
mRNA transcribed in wild-type S. dublin [26]. In the log phase,
only small quantities of single-length spvA mRNA are made.
As cells enter the stationary phase, progressively longer mes-
sages are found, including full-length spvABCD mRNA.
Sequence analysis of SpvR suggested that this protein be-
longs to the large family of LysRlMetR-like transcriptional
activators [28]. These proteins act as single-component regula-
tors of gene expression, and they contain a conserved helix-
tum-helix motif in the NH2 -terminal region involved in DNA
interaction [29]. Genetic studies confirmed that SpvR is abso-
lutely required for spvABCD expression [27]. Knockout muta-
tions in spvR abolish the synthesis of LacZ fusions with the
structural Spv proteins, as well as production of the native Spv
proteins in minicells [23, 26, 27]. SpvR binds to a region
upstream from the spvA transcriptional start sites, and muta-
tions in the helix-tum-helix motif abolish binding in vitro and
activation ofspvA transcription in vivo [30]. However, overpro-
duction of SpvR from constitutive promoters does not abolish
the growth-phase regulation of the spvABCD structural genes,
indicating that the SpvR level is not the sole regulator of spv
expression [26].
The pattern of spv growth-phase regulation strongly sug-
gested the involvement of the alternative a factor RpoS (KatF,
as). The activity of this a factor is induced during post-expo-
nential growth and regulates the stationary-phase expression of
a large set of target genes involved in starvation survival and
environmental stress responses [31]. The central role of RpoS
Figure 2. Mechanism of SPy generegulation on the virulence plas-
mids of Salmonella serovars. Bacterial cells growing in logarithmic
phase in rich culture media do not express the SPy genes (depicted
in the upper cell). However, both post-exponential growth in vitro
and the intracellular environment of host cells in vivo induce the
SPy genes (shown in the lowercell). Induction depends on both the
chromosomal a factorRpoSandtheplasmidregulatory proteinSpvR.
RpoSactivity increases in stationary phaseand in response to nutrient
starvation. RpoSappears to act at both the spvR and spvA promoters.
SpvR is essential for transcription of the spvABCDgenes by binding
to the spvA promoter region. Transcription of the spvABCDstructural
genes is initiated at the spvA promoter, and multiple transcripts are
found.
in spv gene expression was demonstrated by constructing an
rpoS knockout mutation in S. typhimurium [32]. Expression of
spvB is severely decreased in the rpoS mutant. As expected,
the rpoS mutant is markedly attenuated for virulence in mice.
Recent evidence indicates that RpoS is required for optimal
transcription at both the spvR and spvA promoters (figure 2)
([33] and D. G. Guiney, unpublished observations).
Induction of spv Gene Expression by the Host-Cell
Environment
Since considerable indirect evidence suggests that the spv
genes are active in the intracellular environment of the host,
the expression of the SPy genes was examined after uptake of
bacteria by mammalian cells in tissue culture [34]. Fluorescent
(and later luminescent) substrates ofLacZ were used to develop
a sensitive assay for the expression of spv::lacZ fusions by
small numbers ofbacteria inside eukaryotic cells. These studies
have shown that the spv genes are rapidly induced by > 100-
fold on uptake by macrophages, epithelial cells, and hepato-
cytes ([34] and S. Libby, J. Fierer, and D. G. Guiney, unpub-
lished data). Most of the induction occurs within the first hour
following uptake and does not depend on acidification of the
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intracellular vacuole containing the Salmonella strain. This reg-
ulation differs considerably from control of the chromosomal
locus pagC; pagC is regulated by the PhoPlPhoQ two-compo-
nent system and is induced in macrophages, but not epithelial
cells, by a mechanism requiring phagosome acidification over
a period of 3 hours [35J.
These results indicate that spv induction occurs in response
to a general property of the intracellular environment, perhaps
reflecting a relative lack of nutrients available within the endo-
cytic or phagocytic vacuole. Since the intracellular induction
of the spv genes requires both SpvR and RpoS, the genetic
mechanisms regulating post-exponential phase synthesis in
vitro are the same as those controlling the spv operon after
entry into host cells, and presumably throughout the infectious
process (figure 2). The finding that virulence genes are regu-
lated by RpoS suggests that Salmonella strains experience sig-
nificant starvation stress during intracellular infection. Since
the RpoS-mediated response increases bacterial resistance to a
variety of adverse environmental factors, this regulation ap-
pears to be essential for the organism to survive and multiply
in the host.
Plasmid-Cured Salmonella Strains as Live Vaccines
Since plasmid-cured S. dublin produces a self-limited sys-
temic infection with granuloma formation, the ability of this
strain to induce protective immunity was tested in mice [36].
Animals immunized by either oral or intraperitoneal inocula-
tion were protected against lethal challenge with virulent S.
dublin given by oral or intraperitoneal routes of infection. The
fact that intraperitoneal vaccination could protect against a vir-
ulent oral challenge led to the demonstration that systemic as
well as oral salmonella vaccination produces infection of Pey-
er's patches in the intestine. Mice immunized with S. dublin
(group D) were protected against challenge with other group
D Salmonella serovars and also against S. typhimurium (group
B), which shares an O-antigen determinant with group D [36].
Similar results were reported with S. enteritidis (group D) [37].
However, S. dublin does not protect mice from S. choleraesuis
(group C), which lacks any cross-reactive O-antigen epitopes
[36J. It is likely that both lipopolysaccharide and non-lipopoly-
saccharide antigens are important in the protection induced by
live, plasmid-cured strains. These immunization studies have
important implications for vaccine development. The use of
the plasmid-free strain as a vaccine shows that an immune
response to the Spv proteins is not required for protection. Since
plasmid-containing Salmonella serovars are major pathogens of
domestic animals, plasmid-free derivatives could be combined
in a multivalent vaccine for use in livestock.
Conclusions
The plasmid-encoded spv genes enhance the ability ofcertain
non-typhoid Salmonella serovars to produce severe, extraintes-
tinal disease. The spv locus consists of the spvR regulatory
gene and the four structural spvABCD genes. Studies on spv
gene regulation have established the importance of post-expo-
nential or stationary-growth-phase control mechanisms on the
expression of virulence genes in Salmonella strains. The alter-
native (J" factor RpoS, together with SpvR, regulates expression
of the spv operon and ensures rapid induction of the spv genes
within the intracellular environment of the host. Evidence from
pathogenesis studies in mice suggests that the spv genes
enhance the growth of Salmonella species within cells of
the RES.
In clinical practice, non-typhoid salmonella bacteremia and
metastatic infection are associated with a variety of predispos-
ing conditions that decrease natural or acquired immunity, in-
cluding extremes of age, decreased gastric acidity, malignancy,
immunosuppression, and AIDS. The Salmonella serovars caus-
ing systemic disease in these patients are predominantly strains
that carry a virulence plasmid. The virulence-plasmid pheno-
type does not appear to interfere with clearance by acquired
immune mechanisms. By extrapolation from the mouse model,
the spv genes are likely to facilitate growth of the Salmonella
strains within host cells at the sites ofsystemic infection, partic-
ularly in patients who are unable to mount an effective immune
response. Salmonella infection in patients receiving immuno-
suppressive therapy or in patients with AIDS is particularly
difficult to eradicate. The identification of the spv locus pro-
vides a molecular genetic explanation for the propensity of
plasmid-containing serovars to cause serious infections in these
patients.
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